Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LANTUS DIN 02245689

Status: Marketed
Holder: SANOFI-AVENTIS CANADA INC
Molecule: INSULIN GLARGINE
Available to quote

Health Canada record

Active ingredient(s)INSULIN GLARGINE 100 UNIT
Dosage formSolution
RouteSubcutaneous
ScheduleSCHEDULE D
ClassHuman
ATCA10AE04 INSULIN GLARGINE
Original market date24-Jul-2002
Current status date23-Oct-2007
SourceHealth Canada DPD

Establishment licence of the holder

sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing INSULIN GLARGINE

DINProductCompanyFormStrengthStatus
02444844BASAGLARELI LILLY CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02461528BASAGLARELI LILLY CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02251930LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02294338LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02526441SEMGLEEBIOCON SDN.BHDSolutionINSULIN GLARGINE 100 UNITMarketed
02478293SOLIQUASANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNIT; LIXISENATIDE 33 MCGMarketed
02493373TOUJEO DOUBLESTARSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 300 UNITMarketed
02441829TOUJEO SOLOSTARSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 300 UNITMarketed
02444852BASAGLARELI LILLY CANADA INCSolutionINSULIN GLARGINE 100 UNITCancelled Post Market
02276410LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITCancelled Pre Market
02280418LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
79192006-05-03New Drug Submission (NDS)MANUFACTURER NAME CHANGE
6212002-04-03New Drug Submission (NDS)

International API supply for INSULIN GLARGINE

4 active FDA Drug Master Files.

Request a quote for LANTUS

How to read a Canadian DIN record